Schedule 13D ownership disclosure

Madrigal Pharmaceuticals Inc

Security class unavailable · CUSIP: 558868105

Event date: 2018-06-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
34.8500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-19-269284
Form type
SC 13D/A
Filer
BAY CITY CAPITAL LLC
CIK
CIK 1288452
Filed
Oct 17, 2019
Reporting period
Jun 11, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub